Tumor Biology

, Volume 35, Issue 5, pp 4949–4955 | Cite as

Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion

  • Hong Jian
  • Bin Liu
  • Jie Zhang
Research Article


Sema domain of semaphorin 4B (SEMA4B), which is an interacting protein of LNM35, plays an important role in lung cancer invasion. However, the regulation mechanism of this protein is completely unknown. Here, we report that hypoxia and hypoxia mimic reagent could downregulate the expression of SEMA4B in human non-small cell lung cancer (NSCLC) lines. We provide evidences that SEMA4B is a direct target of hypoxia-inducible factor 1 (HIF-1). Silencing the expression of HIF-1α in cancer cells by RNA interference abolished hypoxia-repressed SEMA4B expression. Using luciferase reporter assay, we showed that HIF-1α recognized a hypoxia-responsive element (HRE) of SEMA4B gene, which is required for HIF-1-repressed SEMA4B expression. Moreover, ectopic expression of SEMA4B abolished invasion of hypoxia-induced NSCLC cells. Taken together, these data would shed novel insights on the mechanisms for invasion of hypoxia-induced NSCLC cells.


Sema domain of semaphorin 4B Hypoxia-inducible factor 1 Invasion Lung cancer 



This work was supported by WU JIE PING Medical foundation. We thanks Dr. Liu Ping from Shanghai Institute of Materia Medica, Chinese Academy of Sciences for her kind assistant about the invasion assay.

Conflicts of interest



  1. 1.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMedGoogle Scholar
  2. 2.
    Baltayiannis N, Chandrinos M, Anagnostopoulos D, Zarogoulidis P, Tsakiridis K, Mpakas A, et al. Lung cancer surgery: an up to date. J Thorac Dis. 2013;5:S425–39.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Cooper WA, Lam DC, O’Toole SA, Minna JD. Molecular biology of lung cancer. J Thorac Dis. 2013;5:S479–90.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Maxwell P, Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther. 2004;3:29–35.CrossRefPubMedGoogle Scholar
  5. 5.
    Yang Y, Sun M, Wang L, Jiao B. HIFs, angiogenesis, and cancer. J Cell Biochem. 2013;114:967–74.CrossRefPubMedGoogle Scholar
  6. 6.
    Mamlouk S, Wielockx B. Hypoxia-inducible factors as key regulators of tumor inflammation. Int J Cancer. 2013;132:2721–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Goda N, Kanai M. Hypoxia-inducible factors and their roles in energy metabolism. Int J Hematol. 2012;95:457–63.CrossRefPubMedGoogle Scholar
  8. 8.
    Calzada MJ, del Peso L. Hypoxia-inducible factors and cancer. Clin Transl Oncol. 2007;9:278–89.CrossRefPubMedGoogle Scholar
  9. 9.
    Jackson AL, Zhou B, Kim WY. HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer. Expert Opin Ther Targets. 2010;14:1047–57.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Graves EE, Maity A, Le QT. The tumor microenvironment in non-small-cell lung cancer. Semin Radiat Oncol. 2010;20:156–63.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Scheuermann TH, Yang J, Zhang L, Gardner KH, Bruick RK. Hypoxia-inducible factors Per/ARNT/Sim domains: structure and function. Methods Enzymol. 2007;435:3–24.PubMedGoogle Scholar
  12. 12.
    Metzen E, Ratcliffe PJ. HIF hydroxylation and cellular oxygen sensing. Biol Chem. 2004;385:223–30.PubMedGoogle Scholar
  13. 13.
    Arjumand W, Sultana S. Role of VHL gene mutation in human renal cell carcinoma. Tumour Biol. 2012;33:9–16.CrossRefPubMedGoogle Scholar
  14. 14.
    Caro J. Hypoxia regulation of gene transcription. High Alt Med Biol. 2001;2:145–54.CrossRefPubMedGoogle Scholar
  15. 15.
    Tsai YP, Wu KJ. Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci. 2012;19:102.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, et al. Direct regulation of twist by HIF-1alpha promotes metastasis. Nat Cell Biol. 2008;10:295–305.CrossRefPubMedGoogle Scholar
  17. 17.
    Evans AJ, Russell RC, Roche O, Burry TN, Fish JE, Chow VW, et al. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol. 2007;27:157–69.CrossRefPubMedGoogle Scholar
  18. 18.
    Imai T, Horiuchi A, Wang C, Oka K, Ohira S, Nikaido T, et al. Hypoxia attenuates the expression of E-cadherin via up-regulation of snail in ovarian carcinoma cells. Am J Pathol. 2003;163:1437–47.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Schietke R, Warnecke C, Wacker I, Schodel J, Mole DR, Campean V, et al. The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J Biol Chem. 2010;285:6658–69.CrossRefPubMedGoogle Scholar
  20. 20.
    Nagai H, Sugito N, Matsubara H, Tatematsu Y, Hida T, Sekido Y, et al. CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells. Oncogene. 2007;26:4025–31.CrossRefPubMedGoogle Scholar
  21. 21.
    Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Vadasz Z, Toubi E. Semaphorins: their dual role in regulating immune-mediated diseases. Clin Rev Allergy Immunol 2013. doi: 10.1007/s12016-013-8360-4.
  23. 23.
    Yoshida Y. Semaphorin signaling in vertebrate neural circuit assembly. Front Mol Neurosci. 2012;5:71.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Neufeld G, Sabag AD, Rabinovicz N, Kessler O. Semaphorins in angiogenesis and tumor progression. Cold Spring Harb Perspect Med. 2012;2:a006718.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Gu C, Giraudo E. The role of semaphorins and their receptors in vascular development and cancer. Exp Cell Res. 2013;319:1306–16.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest HospitalShanghai Jiao Tong UniversityShanghaiChina
  2. 2.Shanghai Institute of Materia MedicaChinese Academy of SciencesShanghaiChina
  3. 3.Department of Pathology, Shanghai Chest HospitalShanghai Jiao Tong UniversityShanghaiChina

Personalised recommendations